yes i take peptides · shopping companion

EPO (Erythropoietin)

Epogen / Procrit / Aranesp

Category · For EnergyStatus · FDACitations · 60WADA

The verdict

Yes — inside the FDA-labeled indications (CKD anemia, chemo-induced anemia, zidovudine-induced anemia, surgical pre-op autologous donation), under a nephrologist or hematologist. No — for off-label endurance-performance use; the risk profile is real and the benefit is bannable.

By source — cost, legality, risk

FDA-approved brand (Epogen, Procrit, Aranesp, Mircera)
$300–$1,500/mo (insurance-billed)
Rx required — black-box thrombosis/mortality
Lowest in approved indication (CKD/oncology). Black-box risks apply universally.
Compounded 503A
Not available
Not legally compoundable (biologic glycoprotein)
Cannot be compounded — EPO is a recombinant biologic.
RUO research-chemical site
Not meaningfully available
No legitimate RUO market (biologic)
Listings exist but are typically gray repackaged or counterfeit, not RUO.
Gray-market overseas (Chinese/Eastern European)
Varies — not on user's vendor list (~$150–$500 historically)
Illegal; black-market route
Highest. Counterfeit common. Athlete deaths documented. Pricing volatile and unverified.

Sources · top 5 of 60

01LANGE RD, et al. ERYTHROPOIETIN. Progress in hematology. 1964;4:72-96. PMID: 14274541.
02GRISMONDI GL. [ERYTHROPOIETIN]. Attualita di ostetricia e ginecologia. 1964;10:959-75. PMID: 14305334.
03ACHESON ED. ERYTHROPOIETIN. British medical journal. 1964;1(5390):1060-1. PMID: 14113813.
04BUSOVA B. [ERYTHROPOIETIN]. Lekarsky obzor. 1964;13:113-20. PMID: 14126344.
05GOELTNER E. [ERYTHROPOIETIN IN PREGNANCY AND AFTER LABOR]. Archiv fur Gynakologie. 1964;200:60-87. PMID: 14299427.